Nature

Trends in Peripheral Artery Disease, Lower Extremity Revascularization, and Lower Extremity Amputation in Incident Type 2 Diabetes: A Danish Population-Based Cohort Study

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Oklahoma's News

New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)

Findings presented at ACC.23 show XARELTO ® plus aspirin provides a 33 percent reduction in acute limb ischemia following LER, with consistent benefit demonstrated at 30 days, 90 days and up to three ...
FiercePharma

ACC23: Bayer and J&J's Xarelto reduces ischemia risk for PAD patients after revascularization surgery

Lower extremity revascularization (LER), a surgical procedure that can restore blood flow to blocked arteries in the legs, is often necessary for people with peripheral artery disease (PAD). While it ...
TCTMD

TCT 243: Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below: Receive the the latest news, research, and presentations from major meetings ...
EurekAlert!

Multidisciplinary panel advocates for increased adoption of Intravascular Ultrasound (IVUS) in peripheral vascular interventions

WASHINGTON (January 9, 2024) – Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ultrasound (IVUS) in lower extremity revascularization procedures were ...
Healio

Expert panel: IVUS can benefit patients needing peripheral revascularization

Please provide your email address to receive an email when new articles are posted on . IVUS may improve care of patients undergoing peripheral revascularization. More data are needed to document ...